Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant
NCT00456482
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
239
Enrollment
INDUSTRY
Sponsor class
Stopped
SARS epidemic in Asia and Canada
Conditions
Non-infectious Uveitis
Interventions
DRUG:
Fluocinolone Acetonide 0.59mg
DRUG:
Fluocinolone Acetonide 2.1mg
Sponsor
Bausch & Lomb Incorporated